Alysophil
Alysophil is a French deeptech company combining AI, continuous-flow chemistry, real-time analytics, and compact micro-factories to enable on-demand molecule generation and manufacturing for pharmaceutical, chemical, defense, and advanced-materials companies globally.
- Company typePrivate
- Founded2017
- HeadquartersIllkirch, France
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Alysophil does
Alysophil is a French private deeptech company with 11-50 employees that develops AI-enabled continuous-flow manufacturing systems for chemical and pharmaceutical companies. Its technology stack combines continuous-flow reactors, AI-driven process optimization and autonomous control, digital twins, and in-line NMR, with deployment centered on localized, just-in-time production of APIs and specialty chemicals. The company also uses molecule generation to address customer-specific synthesis requirements.
Commercial offerings include AlChemAI, a chemistry platform for structure-property modeling, constrained de novo molecule generation, anomaly detection, and process optimization; ChemPocket, a 25m² micro-factory claimed to produce up to 3,000 tonnes annually; and AlchemDrive, an edge-AI controller for industrial production equipment. Alysophil also participates in PIPAc, an autonomous continuous API-manufacturing system integrating flow chemistry, in-line benchtop NMR, digital twins, and AI control that was validated on fentanyl and propofol workflows.
Alysophil's stated revenue mechanics combine ChemPocket sale or lease and Chemical-as-a-Service deployment, AI-enabled molecule-generation and process-optimization services, and licensing or co-commercialization through PIPAc. Its go-to-market relies on direct enterprise engagement with large pharmaceutical and industrial customers, supplemented by strategic partnerships and consortium-led demonstrations; public list prices and contract values are not disclosed. Pharmaceutical and life-sciences applications are the primary served segment, with additional activity in defense, aerospace, cosmetics, aromas and fragrances, construction, electronics, and advanced manufacturing.
Alysophil firmographics
Firmographics- Name
- Alysophil
- Legal name
- ALYSOPHIL SAS
- Website
- https://alysophil.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Alysophil is a French deeptech company combining AI, continuous-flow chemistry, real-time analytics, and compact micro-factories to enable on-demand molecule generation and manufacturing for pharmaceutical, chemical, defense, and advanced-materials companies globally.
- Ownership category
- akta.pro rank
Alysophil industry classification
Industry- Product category
- Specialty Chemical Manufacturing Technology
- NAICS
- Chemical Manufacturing (325), Pharmaceutical and Medicine Manufacturing (32541), All Other Chemical Product and Preparation Manufacturing (32599)
- SIC
- Industrial Organic Chemicals (2860), Chemicals & Allied Products (2800), Miscellaneous Chemical Products (2890)
- akta.pro primary industry
- Flow Chemistry & Process Intensification Services (HLAGAHAK)
- akta.pro secondary industries
- AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO), AI/ML Engineering & Model Development Services (BPAEAHAF), Process Mining, Predictive Process Analytics & Automation Intelligence (HDAAAHAJ)
Keywords
Where Alysophil is headquartered
LocationHeadquarters
- HQ city
- Illkirch
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Alysophil business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Revenue model
- Micro-factory (ChemPocket) sales / Chemical-as-a-Service: Sale or lease of ChemPocket micro-factory units to industrial customers, enabling localized continuous flow chemical production. Positioned as 'Chemical as a Service' model, implying a managed service or unit-based pricing structure for on-site chemical manufacturing.
- AI-powered molecule generation and process optimization services: Generation of novel molecules (1M+ library) and AI-driven process optimization services for customer-specific synthesis challenges across pharmaceuticals, cosmetics, flavors, defense, and specialty chemicals.
- Licensing / co-development of PIPAc platform technology: PIPAc consortium platform — co-developed autonomous manufacturing technology — is brought to market through licensing or co-commercialization arrangements with consortium partners (Bruker, NovAliX, De Dietrich Process Systems) for pharmaceutical API production.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Alysophil product offering
Product offeringCore offering
Alysophil develops AI-augmented continuous flow chemistry solutions delivered through its ChemPocket modular micro-factory (25m² footprint producing up to 3,000 tonnes/year). The company sells hardware units (ChemPocket), AI software platforms (AlChemAI for molecule generation and process optimization, AlchemDrive for edge AI process control), and contract research services to pharmaceutical, specialty chemical, defense, and cosmetics manufacturers seeking localized, on-demand chemical production.
Product overview
Alysophil operates as a deeptech company offering intelligent flow chemistry solutions augmented with AI. The core product portfolio consists of AlChemAI (an AI platform for molecule generation, structure-property analysis, and process optimization), ChemPocket (a compact 25m² micro-factory for continuous flow chemical production up to 3,000 tonnes/year), and AlchemDrive (Edge AI for autonomous industrial control). These products are interconnected: AlChemAI drives the intelligent control of ChemPocket micro-factories and the PIPAc consortium-developed pharmaceutical manufacturing platform. The company targets pharmaceutical, defense, aerospace, fragrance, cosmetics, and construction sectors with solutions for supply chain resilience and on-demand manufacturing.
Differentiator
Problem solved
Functional benefit
Brands
- AlChemAI: AI platform for chemistry applications including structure-property relationships, molecule generation under constraints, process optimization, anomaly detection, and production control.
- ChemPocket
- AlchemDrive
- PIPAc
Products and services
- ChemPocket Micro-Factory A modular continuous flow chemistry micro-factory in a container-sized 25m² footprint capable of producing up to 3,000 tonnes per year. Sold or leased to industrial customers for on-site, on-demand production of specialty chemicals and APIs, enabling just-in-time manufacturing and relocalization of chemical activities.
- AlChemAI AI-powered platform providing solutions across the chemical value chain (research, modeling, production) including structure-property relationships (toxicity prediction, odor anticipation), de novo molecule generation under constraints, manufacturing process optimization, anomaly detection, and autonomous flow production control. Backed by a proprietary library of 1 million never-before-synthesized molecules generated by deep neural networks trained since 2017.
- AlchemDrive Edge AI solution for autonomous industrial piloting of polymer and material production equipment, enabling real-time adaptive control without cloud dependency.
- PIPAc Platform AI-driven autonomous continuous manufacturing platform integrating continuous flow chemistry, in-line benchtop NMR spectroscopy, digital twin technology, and AI control systems for pharmaceutical API production. Co-developed by the PIPAc consortium (Alysophil, Bruker, NovAliX, De Dietrich Process Systems). Validated on fentanyl and propofol workflows with real-time monitoring and adaptive optimization.
Quantifiable outcome
- Up to 3,000 tonnes/year production capacity from a 25m² micro-factory unit
- +2 more outcomes
Companies that use Alysophil
Customer profileSegments7 records
Ideal customer profiles4 records
Alysophil technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature5 records
Alysophil partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and major.
- PIPAc Consortium (Bruker, NovAliX, De Dietrich Process Systems)coreThe PIPAc consortium — comprising Bruker (NMR/in-line analytics), NovAliX (pharmaceutical manufacturing), De Dietrich Process Systems (process equipment), and Alysophil (AI/flow chemistry) — successfully validated an AI-driven autonomous continuous manufacturing platform for pharmaceutical APIs. The platform integrates continuous flow chemistry, in-line NMR spectroscopy, digital twin technology, and AI control systems. Validated on fentanyl and propofol workflows demonstrating real-time monitoring and adaptive optimization. The consortium brings Pharma 4.0-aligned, just-in-time pharmaceutical manufacturing to market.
- TotalEnergiesmajorTotalEnergies renewed its collaboration with Alysophil and Quandela to continue applying AI and quantum computing to the design of innovative materials. The partnership focuses on developing advanced materials using quantum computing-enhanced neural networks for polymer design.
- MBDAmajorMBDA (defense and aerospace company) renewed its collaboration with Alysophil and Quandela for AI and quantum computing applications in innovative materials design. MBDA also co-funded the CLEE project (high-energy liquid fuels in continuous flow) and the quantum computing polymer synthesis project initiated in 2022.
- QuandelamajorQuandela and Alysophil have collaborated since 2022 (renewed 2025) on applying quantum computing and AI to polymer synthesis. The project, co-funded by MBDA, aims to develop neural networks for quantum computers to propose new polymer solutions for advanced materials markets.
- De Dietrich Process SystemscoreDe Dietrich Process Systems made a strategic equity investment in Alysophil and formed a partnership to strengthen expertise in continuous flow chemistry. De Dietrich integrates Alysophil's flow chemistry capabilities into its process equipment portfolio, serving as a key channel to industrial customers globally.
- InriamajorInria (French National Institute for Digital Science) partnered with Alysophil and MBDA on the CLEE project, funded by the French Defense Innovation Agency (AID), for the manufacturing of High-Energy Liquid Fuels (CLEE) in continuous flow and the development of novel fuels.
- NovAliXcoreSeven-year partnership with NovAliX (since 2019 at Bioparc d'Illkirch). NovAliX provides pharmaceutical manufacturing expertise to the PIPAc consortium alongside Alysophil's AI and flow chemistry capabilities. Alysophil's new headquarters at Campus Ourisson follows a seven-year NovAliX partnership, suggesting deep operational integration.
- BrukercoreBruker provides in-line benchtop NMR spectroscopy for real-time process monitoring and quality assurance within the PIPAc autonomous manufacturing platform. Bruker's NMR technology is a core analytical component enabling closed-loop AI control of continuous flow chemical reactions.
Scale indicators4 records
Recent moves7 records
Expansion highlights6 records
Alysophil competitors and assessment
Company assessmentDirect peers
- H.E.L Group: UK-based manufacturer of flow chemistry (FlowCAT) and process safety/reaction calorimetry instruments for pharma, chemicals and battery R&D. Comparable in serving process development customers with continuous reactor and process-analytic technology.
- Vapourtec: UK-based manufacturer of continuous flow chemistry reactors and systems for pharma and fine chemicals R&D and production. Directly competes with ChemPocket as a modular flow chemistry platform, though without Alysophil's AI/edge-control layer.
- Ehrfeld Mikrotechnik BTS: German supplier of modular flow chemistry and microreactor technology (FlowPlate, Lonza-Fox) for process development and production. Direct peer in containerized, production-scale flow chemistry moving into pharma manufacturing.
- Syrris: Developer of flow chemistry systems (Asia, Atlas, Titan) for laboratory and process-scale chemical manufacturing. Closely comparable to Alysophil's flow chemistry micro-factory approach across pharma and specialty chemicals customers.
- Chemtrix: Dutch provider of continuous flow reactors (Protrix, KiloFlow, Plantrix) from lab to production scale. Comparable modular flow-chemistry play targeting the same pharma and fine-chemicals use cases as ChemPocket.
Broad incumbents
- Schrödinger: Computational chemistry and molecular simulation platform used for drug discovery and materials design. Adjacent to AlChemAI's generative molecule and property-prediction capabilities, but focused on software rather than physical flow chemistry.
- Citrine Informatics: AI platform for materials and chemicals R&D, including formulation and process optimization. Comparable to the AI-driven process optimization layer of Alysophil's stack, applied to specialty chemicals and materials customers.
- Corning Advanced-Flow Reactors (AFR): Division of Corning offering industrial-scale continuous flow reactors (G1, G3, G4) widely adopted in pharma and specialty chemicals. Broad incumbent with overlapping flow chemistry capability, but no integrated AI/digital-twin stack comparable to AlChemAI.
Emerging players
- Asymchem (Snapdragon Chemistry): CDMO with a strong continuous flow chemistry and automation offering for API development and manufacturing. Comparable as a commercial-scale flow-chemistry player in pharma, partially overlapping Alysophil's PIPAc use cases.
- Cradle: Generative AI platform for protein and molecule design. Comparable to AlChemAI's generative molecule capabilities and use of AI for designing novel high-value molecules, though Cradle focuses on biologics rather than flow-chemistry manufacturing.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights5 records
Customer concentration
Alysophil social profiles
Digital presenceAlysophil financial estimates
Financial estimateRevenue estimate
Valuation estimate
Alysophil leadership team
Management profileNumber of profiles
Profiles1 record
Alysophil funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Alysophil M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Alysophil
What does Alysophil do?
Alysophil develops AI-augmented continuous flow chemistry solutions delivered through its ChemPocket modular micro-factory (25m² footprint producing up to 3,000 tonnes/year). The company sells hardware units (ChemPocket), AI software platforms (AlChemAI for molecule generation and process optimization, AlchemDrive for edge AI process control), and contract research services to pharmaceutical, specialty chemical, defense, and cosmetics manufacturers seeking localized, on-demand chemical production.
Is Alysophil a public or private company?
Alysophil is a private company. It is classified as venture growth investor backed and is currently operating.
When was Alysophil founded?
Alysophil was founded in 2017. It employs 11 to 50 people.
Where is Alysophil based?
Alysophil is headquartered in Illkirch, France, in the Europe region.
How does Alysophil make money?
Three revenue lines are on record. Micro-factory (ChemPocket) sales / Chemical-as-a-Service is the primary driver. The others are AI-powered molecule generation and process optimization services and licensing / co-development of PIPAc platform technology.
Who are Alysophil's main competitors?
Direct peers on record are H.E.L Group, Vapourtec, Ehrfeld Mikrotechnik BTS, Syrris and Chemtrix. Broad incumbents are Schrödinger, Citrine Informatics and Corning Advanced-Flow Reactors (AFR). Emerging players are Asymchem (Snapdragon Chemistry) and Cradle.
Does Alysophil have an API?
No public API is recorded for Alysophil.
What industry is Alysophil in?
Alysophil's product category is Specialty Chemical Manufacturing Technology. Its primary akta.pro industry code is HLAGAHAK, Flow Chemistry & Process Intensification Services, with a secondary code of HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization. Its NAICS code is 325 and its SIC code is 2860.